Abstract
Abstract:
The present invention relates to crystalline forms of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4fluorophenyl)cyclopropane-1,1-dicarboxamide maleate represented by the following structural formula-1a, which is referred to as Cabozantinib maleate.
Formula-1a
The present invention also relates to crystalline form of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4fluorophenyl)cyclopropane-1,1-dicarboxamide fumarate represented by the following structural formula-1b, which is referred to as Cabozantinib fumarate.
Formula-1b
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan, Sajja Eswaraiah, Vijayavitthal T. Mathad, Saladi Venkata Narasayya, Kammari Bal Raju, "Crystalline forms of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4 fluorophenyl) cyclopropane-1,1-dicarboxamide salts and process for its preparation thereof", Technical Disclosure Commons, (November 07, 2023)
https://www.tdcommons.org/dpubs_series/6400